Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene versus butorphanol for prevention of intrathecal morphine-induced pruritus after cesarean delivery
ChiCTR1900022268Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pruritus comparing Nalmefene group with Butorphanol group (2 arms). Primary endpoint: Pruritus. Planned start May 2019; status: not yet recruiting.
02
Drugs
nalmefenebutorphanol
03
Conditions
pruritus
Beyond the preview
Go deeper on ChiCTR1900022268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022268.